Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?

Gnant, Michael; Dubsky, Peter; Fitzal, Florian; Blaha, Peter; Schoppmann, Sebastian; Steger, Günther; Marth, Christian; Samonigg, Hellmut; Hüttner, Katharina; Fohler, Hannes; Ruecklinger, Ernst; Jakesz, Raimund; Greil, Richard

Gnant, Michael; Dubsky, Peter; Fitzal, Florian; Blaha, Peter; Schoppmann, Sebastian; Steger, Günther; Marth, Christian; Samonigg, Hellmut; Hüttner, Katharina; Fohler, Hannes; Ruecklinger, Ernst; Jakesz, Raimund; Greil, Richard.

Affiliation

Gnant M; Department of Surgery, Medical University of Vienna, Vienna, Austria. michael.gnant@meduniwien.ac.at

Clin Breast Cancer ; 9 Suppl 1: S18-27, 2009 Jun.

Article in En | MEDLINE | ID: mdl-19561003

Subject(s)

Adjuvants, Pharmaceutic/therapeutic use; Bone Density/drug effects; Bone Diseases, Metabolic/drug therapy; Breast Neoplasms/therapy; Antineoplastic Agents/adverse effects; Bone Density Conservation Agents/therapeutic use; Bone Diseases, Metabolic/chemically induced; Bone Diseases, Metabolic/physiopathology; Breast Neoplasms/physiopathology; Clinical Trials as Topic; Diphosphonates/therapeutic use; Female; Humans

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Bone Diseases, Metabolic / Breast Neoplasms / Bone Density / Adjuvants, Pharmaceutic Type of study: Clinical_trials Language: En Journal: Clin Breast Cancer Year: 2009 Type: Article Affiliation country: Austria

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google